Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06085209 · ClinicalTrials.gov registry record · Phase 1
Cryospray Therapy for Benign Airway Stenosis
A Phase 1 study of Stenosis Trachea, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06085209 is a Phase 1 study of Stenosis Trachea that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06085209, a Phase 1 study of Stenosis Trachea, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical evaluation to assess the effectiveness of cryospray therapy used in addition to current standard of care endoscopic therapies in preventing short term recurrent airway stenosis with a multicentric outcome evaluation. The investigators hypothesize that the addition of SCT to standard endoscopic treatment of benign airway stenosis will result in decreased stenosis recurrence at 6 months as estimated by quantitative radiologic assessment of the stenotic volume.
Conditions Studied
Interventions
- DEVICE The truFreeze Spray Cryotherapy
- DEVICE Ballon dilation
- DEVICE Radial Incision
Study Locations (1)
Virginia
- Virgnia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06085209
The ClinicalTrials.gov registry entry for NCT06085209 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stenosis Trachea appearing as the primary indexed condition, and to 3 interventions - of which The truFreeze Spray Cryotherapy is the first listed.
NCT06085209 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06085209 about?
NCT06085209 is a clinical study titled "Cryospray Therapy for Benign Airway Stenosis". This is a clinical evaluation to assess the effectiveness of cryospray therapy used in addition to current standard of care endoscopic therapies in preventing short term recurrent airway stenosis with a multicentric outcome evaluation. The investigators hypothesize that the addition of SCT to standa...
What is the current status of trial NCT06085209?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2023-10-12. Estimated completion is 2026-12-30.
What conditions does trial NCT06085209 study?
This clinical trial studies the following conditions: Stenosis Trachea.
What interventions are being tested in trial NCT06085209?
The interventions under investigation include: The truFreeze Spray Cryotherapy (DEVICE), Ballon dilation (DEVICE), Radial Incision (DEVICE).
Who is sponsoring clinical trial NCT06085209?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06085209 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.